Quantum Biopharma (NASDAQ:QNTM) Raised to Sell at Wall Street Zen

Quantum Biopharma (NASDAQ:QNTM) was upgraded by equities research analysts at Wall Street Zen from a “strong sell” rating to a “sell” rating in a research report issued on Saturday.

Separately, Weiss Ratings lowered shares of Quantum Biopharma from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, May 28th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock has an average rating of “Sell”.

Quantum Biopharma Stock Performance

Shares of QNTM stock opened at $2.89 on Friday. Quantum Biopharma has a fifty-two week low of $2.07 and a fifty-two week high of $31.91. The firm has a market capitalization of $18.50 million, a price-to-earnings ratio of -0.35 and a beta of 0.45. The stock’s 50-day simple moving average is $4.01 and its 200-day simple moving average is $4.28.

Hedge Funds Weigh In On Quantum Biopharma

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Virtu Financial LLC acquired a new stake in Quantum Biopharma during the 4th quarter worth about $76,000. Jane Street Group LLC purchased a new stake in Quantum Biopharma during the 4th quarter valued at about $80,000. Finally, Platform Technology Partners acquired a new position in shares of Quantum Biopharma in the first quarter valued at about $199,000. Hedge funds and other institutional investors own 1.24% of the company’s stock.

Quantum Biopharma Company Profile

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company’s three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS. The Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial property.